THYMOSINE ALPHA 1 DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA MUCOVISCIDOSE
- 专利权人:
- GARACI, ENRICO;ROMANI, LUIGINA;ROMANI; LUIGINA
- 发明人:
- ROMANI, LUIGINA,GARACI, ENRICO
- 申请号:
- CA2976062
- 公开号:
- CA2976062A1
- 申请日:
- 2016.02.04
- 申请国别(地区):
- CA
- 年份:
- 2016
- 代理人:
- 摘要:
- The present invention concerns Thymosin alpha 1 (Ta1) for use in treatment of cystic fibrosis as a CFTR corrector, CFTR potentiator and anti-inflammatory agent.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- SMALL MOLECULE CFTR CORRECTORS
- CYCLOPROPANECARBOXAMIDE MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR